Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 11/20 | 0.46 |
| ▸ | CNR1 | P21554 | 7/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | CASP7 | P55210 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.38 |
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.37 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.36 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | NOS1 | P29475 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25733267 | 1.00 | CNR2 (0.46) | CNR2CNR1ALDH1A1CYP1A2HSD17B10 | |
| SCHEMBL25733192 | 0.86 | KDM4E (0.42) | ALDH1A1HSD17B10TSHRCASP1HDAC1 | |
| SCHEMBL31731022 | 0.86 | KDM4E (0.42) | ALDH1A1HSD17B10TSHRCASP1HDAC1 | |
| SCHEMBL31730864 | 0.86 | EGLN1 (0.40) | CNR2CNR1ALDH1A1CYP1A2HSD17B10 | |
| SCHEMBL25733329 | 0.86 | EGLN1 (0.40) | CNR2CNR1ALDH1A1CYP1A2HSD17B10 | |
| SCHEMBL25232694 | 0.85 | EGLN1 (0.44) | CNR2CNR1ALDH1A1CYP1A2HSD17B10 | |
| Hydrochloric Acid SCHEMBL25281828 | 0.84 | EGLN1 (0.43) | CNR2CNR1ALDH1A1CYP1A2HSD17B10 | |
| SCHEMBL31730946 | 0.83 | CNR2 (0.43) | CNR2CNR1ALDH1A1CYP1A2HSD17B10 | |
| SCHEMBL25733331 | 0.83 | CNR2 (0.43) | CNR2CNR1ALDH1A1CYP1A2HSD17B10 | |
| SCHEMBL31730971 | 0.83 | CNR2 (0.43) | CNR2CNR1ALDH1A1CYP1A2HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250353851-A1 | PURINES AND METHODS OF THEIR USE | KINETA INC (US) | 2025-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250353851-A1 | PURINES AND METHODS OF THEIR USE | TDP1, TDP2, PIKFYVE | CNR2 4215/4885CNR1 4210/4885ALDH1A1 4617/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.